- Country: Czech Republic
- Summary: Medicinal Preparations with the Active Substance Siltuximab
- CZT Ref No: 131135975
- Deadline: 29 Dec 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.:Login to see details
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details.
- Documents:
8de10eadda8e70b4a124e0583d3046cf.zadavaci.dokumentace.pdf
dca5a40d5a3f915124db962160fe7865.priloha.c.1.tabulka.pro.vypocet.nabidkove.ceny_baleni.xlsx
f9987a0d3d448d0861b313451b9850c6.priloha.c.2.ramcova.kupni.smlouva.docx
db52dda29501cea5b711ab59d1c69124.priloha.c.3.kryci.list.a.cestne.prohlaseni.docx
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINMedicinal Preparations with the Active Substance Siltuximab - Czech Tender
The UNIVERSITY HOSPITAL BRNO, a Government sector organization in Czech Republic, has announced a new tender for Medicinal Preparations with the Active Substance Siltuximab. This tender is published on CzechTenders under CZT Ref No: 131135975 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-12-29.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
